Advanced Eye Care, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 311 E Ray Fine Blvd, Suite 5, Roland, OK 74954 Phone: 918-427-3937 Fax: 918-427-8882 |
Mrs. Maygen J Enochs-wilson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 311 E Ray Fine Blvd Ste 5, Roland, OK 74954 Phone: 918-427-3937 Fax: 918-427-8882 |
Dr. Kimberley Ann Brunk, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1022 East Ray Fine Boulevard Suite 5, Roland, OK 74954 Phone: 918-427-3937 |
News Archive
InDex Pharmaceuticals today announced that it has been granted a patent by the United States Patent and Trademark Office. The patent provides additional protection for the use of Kappaproct® and additional DNA-based immunomodulatory sequences (DIMS) for the treatment of steroid-resistant inflammatory diseases including inflammatory bowel disease, rheumatoid arthritis, psoriasis, asthma, emphysema and chronic obstructive pulmonary disease.
The drug anastrozole is effective in treating an early form of breast cancer, according to a clinical trial led by Queen Mary University of London. The results of the IBIS-II DCIS trial show that anastrozole is as effective as tamoxifen for this type of breast cancer and could offer a new treatment option for post-menopausal women.
The advance market commitment plan aimed at funding the development of vaccines for diseases - including HIV/AIDS, tuberculosis and malaria - that largely affect developing countries is "a new way for partners in the private and public sectors to solve an old problem".
New long-lasting weekly injections of fertility hormones are as safe and effective as standard daily injections, according to Cochrane researchers. The researchers compared weekly and daily hormone injections in a Cochrane systematic review and found no difference in pregnancies or serious side effects between the two regimens.
Cardio3 BioSciences, a leader in the discovery, development and commercialization of regenerative, protective and reconstructive therapies, announces today the signing of a preferred access agreement with Mayo Clinic.
› Verified 3 days ago